newsfilter
← Latest News
GlobeNewswire·

Immix Biopharma to Host Conference Call for Investors, Analysts and Members of the Media

- Company management will provide an update on positive new developments regarding CAR-T NXC-201 in relapsed/refractory AL Amyloidosis. Following management's formal remarks, there will be a question-and-answer session.